Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Tarsus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Tarsus Pharmaceuticals Inc
Rating: 1.280083375
Author: Trendlyne DVM scores

Momentum Trap

about

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

77.46 -0.63 (-0.81%)

43.84% Gain from 52W Low

487.1K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

11.8 / 100

Technically Neutral

57.2 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 26%

9 analysts

Tarsus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

43.84% Gain from 52W Low

SWOT Analysis

Tarsus Pharma Inc Live Price Chart

Tarsus Pharma Inc Live Price Chart